Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 1
1997 6
1998 4
1999 1
2002 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia.
Panetta JC, Yanishevski Y, Pui CH, Sandlund JT, Rubnitz J, Rivera GK, Ribeiro R, Evans WE, Relling MV. Panetta JC, et al. Among authors: yanishevski y. Cancer Chemother Pharmacol. 2002 Nov;50(5):419-28. doi: 10.1007/s00280-002-0511-x. Epub 2002 Sep 24. Cancer Chemother Pharmacol. 2002. PMID: 12439601 Clinical Trial.
In vivo toxicity and pharmacokinetic features of B43(Anti-CD19)-Genistein immunoconjugate.
Ek O, Yanishevski Y, Zeren T, Waurzyniak B, Gunther R, Chelstrom L, Chandan-Langlie M, Schneider E, Myers DE, Evans W, Uckun FM. Ek O, et al. Among authors: yanishevski y. Leuk Lymphoma. 1998 Jul;30(3-4):389-94. doi: 10.3109/10428199809057550. Leuk Lymphoma. 1998. PMID: 9713969
In vivo toxicity and pharmacokinetic features of B43 (anti-CD19)-genistein immunoconjugate in nonhuman primates.
Messinger Y, Yanishevski Y, Ek O, Zeren T, Waurzyniak B, Gunther R, Chelstrom L, Chandan-Langlie M, Schneider E, Myers DE, Evans W, Uckun FM. Messinger Y, et al. Among authors: yanishevski y. Clin Cancer Res. 1998 Jan;4(1):165-70. Clin Cancer Res. 1998. PMID: 9516966 Free article.
Pharmacokinetic features, immunogenicity, and toxicity of B43(anti-CD19)-pokeweed antiviral protein immunotoxin in cynomolgus monkeys.
Uckun FM, Yanishevski Y, Tumer N, Waurzyniak B, Messinger Y, Chelstrom LM, Lisowski EA, Ek O, Zeren T, Wendorf H, Langlie MC, Irvin JD, Myers DE, Fuller GB, Evans W, Gunther R. Uckun FM, et al. Among authors: yanishevski y. Clin Cancer Res. 1997 Mar;3(3):325-37. Clin Cancer Res. 1997. PMID: 9815689 Free article.
Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia.
Nishigaki H, Ito C, Manabe A, Kumagai M, Coustan-Smith E, Yanishevski Y, Behm FG, Raimondi SC, Pui CH, Campana D. Nishigaki H, et al. Among authors: yanishevski y. Blood. 1997 May 15;89(10):3735-44. Blood. 1997. PMID: 9160679
In vivo toxicity, pharmacokinetics, and antileukemic activity of TXU (anti-CD7)-pokeweed antiviral protein immunotoxin.
Waurzyniak B, Schneider EA, Tumer N, Yanishevski Y, Gunther R, Chelstrom LM, Wendorf H, Myers DE, Irvin JD, Messinger Y, Ek O, Zeren T, Langlie MC, Evans WE, Uckun FM. Waurzyniak B, et al. Among authors: yanishevski y. Clin Cancer Res. 1997 Jun;3(6):881-90. Clin Cancer Res. 1997. PMID: 9815763 Free article.
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia.
Relling MV, Yanishevski Y, Nemec J, Evans WE, Boyett JM, Behm FG, Pui CH. Relling MV, et al. Among authors: yanishevski y. Leukemia. 1998 Mar;12(3):346-52. doi: 10.1038/sj.leu.2400928. Leukemia. 1998. PMID: 9529129 Free article.
Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
Krynetski EY, Krynetskaia NF, Yanishevski Y, Evans WE. Krynetski EY, et al. Among authors: yanishevski y. Mol Pharmacol. 1995 Jun;47(6):1141-7. Mol Pharmacol. 1995. PMID: 7603453
Treatment of human B-cell precursor leukemia in SCID mice using a combination of the investigational biotherapeutic agent B43-PAP with cytosine arabinoside.
Messinger Y, Yanishevski Y, Avramis VI, Ek O, Chelstrom LM, Gunther R, Myers DE, Irvin JD, Evans W, Uckun FM. Messinger Y, et al. Among authors: yanishevski y. Clin Cancer Res. 1996 Sep;2(9):1533-42. Clin Cancer Res. 1996. PMID: 9816330 Free article.
Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulation.
Belkov VM, Krynetski EY, Schuetz JD, Yanishevski Y, Masson E, Mathew S, Raimondi S, Pui CH, Relling MV, Evans WE. Belkov VM, et al. Among authors: yanishevski y. Blood. 1999 Mar 1;93(5):1643-50. Blood. 1999. PMID: 10029593 Clinical Trial.
15 results
Jump to page
Feedback